120 related articles for article (PubMed ID: 17126016)
1. Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor.
Liang R; Abrardo L; Brady EJ; Candelore MR; Ding V; Saperstein R; Tota LM; Wright M; Mock S; Tamvakopolous C; Tong S; Zheng S; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2007 Feb; 17(3):587-92. PubMed ID: 17126016
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists.
Shen DM; Zhang F; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Dragovic J; Feeney WP; Jiang G; McCann PE; Mock S; Qureshi SA; Saperstein R; Shen X; Tamvakopoulos C; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2005 Oct; 15(20):4564-9. PubMed ID: 16102966
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent, orally active benzimidazole glucagon receptor antagonists.
Kim RM; Chang J; Lins AR; Brady E; Candelore MR; Dallas-Yang Q; Ding V; Dragovic J; Iliff S; Jiang G; Mock S; Qureshi S; Saperstein R; Szalkowski D; Tamvakopoulos C; Tota L; Wright M; Yang X; Tata JR; Chapman K; Zhang BB; Parmee ER
Bioorg Med Chem Lett; 2008 Jul; 18(13):3701-5. PubMed ID: 18539028
[TBL] [Abstract][Full Text] [Related]
4. Discovery of tetralin ureas as potent melanin concentrating hormone 1 receptor antagonists.
Guo T; Gu H; Hobbs DW; Busler DE; Rokosz LL
Bioorg Med Chem Lett; 2007 Mar; 17(6):1718-21. PubMed ID: 17251014
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of canine glucagon receptor and its use to evaluate glucagon receptor antagonists in vitro and in vivo.
Yang X; Yates ML; Candelore MR; Feeney W; Hora D; Kim RM; Parmee ER; Berger JP; Zhang BB; Qureshi SA
Eur J Pharmacol; 2007 Jan; 555(1):8-16. PubMed ID: 17140563
[TBL] [Abstract][Full Text] [Related]
6. Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties.
Madsen P; Kodra JT; Behrens C; Nishimura E; Jeppesen CB; Pridal L; Andersen B; Knudsen LB; Valcarce-Aspegren C; Guldbrandt M; Christensen IT; Jørgensen AS; Ynddal L; Brand CL; Bagger MA; Lau J
J Med Chem; 2009 May; 52(9):2989-3000. PubMed ID: 19385613
[TBL] [Abstract][Full Text] [Related]
7. Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity.
Galiano S; Ceras J; Cirauqui N; Pérez S; Juanenea L; Rivera G; Aldana I; Monge A
Bioorg Med Chem; 2007 Jun; 15(11):3896-911. PubMed ID: 17407817
[TBL] [Abstract][Full Text] [Related]
8. Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists.
Dallas-Yang Q; Shen X; Strowski M; Brady E; Saperstein R; Gibson RE; Szalkowski D; Qureshi SA; Candelore MR; Fenyk-Melody JE; Parmee ER; Zhang BB; Jiang G
Eur J Pharmacol; 2004 Oct; 501(1-3):225-34. PubMed ID: 15464082
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core.
Shen DM; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Feeney WP; Jiang G; McCann ME; Mock S; Qureshi SA; Saperstein R; Shen X; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2011 Jan; 21(1):76-81. PubMed ID: 21147532
[TBL] [Abstract][Full Text] [Related]
10. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
[TBL] [Abstract][Full Text] [Related]
11. New beta-alanine derivatives are orally available glucagon receptor antagonists.
Lau J; Behrens C; Sidelmann UG; Knudsen LB; Lundt B; Sams C; Ynddal L; Brand CL; Pridal L; Ling A; Kiel D; Plewe M; Shi S; Madsen P
J Med Chem; 2007 Jan; 50(1):113-28. PubMed ID: 17201415
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and effects of novel phenylpyrimidines as glucagon receptor antagonists.
Choi H; Lee CY; Park EY; Lee KM; Shin D; Jun HS
Bioorg Med Chem; 2018 Nov; 26(21):5701-5710. PubMed ID: 30366787
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors.
Yan L; Hale JJ; Lynch CL; Budhu R; Gentry A; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Rosen H; Mandala SM
Bioorg Med Chem Lett; 2004 Oct; 14(19):4861-6. PubMed ID: 15341940
[TBL] [Abstract][Full Text] [Related]
14. Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor.
Cohen SM; Duffy JL; Miller C; Kirk BA; Candelore MR; Ding VD; Kaczorowski G; Tota LM; Werrmann JG; Wright M; Parmee ER; Tata JR; Zhang BB
Bioorg Med Chem; 2006 Mar; 14(5):1506-17. PubMed ID: 16256355
[TBL] [Abstract][Full Text] [Related]
15. Biaryl amide glucagon receptor antagonists.
Kurukulasuriya R; Sorensen BK; Link JT; Patel JR; Jae HS; Winn MX; Rohde JR; Grihalde ND; Lin CW; Ogiela CA; Adler AL; Collins CA
Bioorg Med Chem Lett; 2004 May; 14(9):2047-50. PubMed ID: 15080976
[TBL] [Abstract][Full Text] [Related]
16. Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonists.
Zhang M; Tamiya J; Nguyen L; Rowbottom MW; Dyck B; Vickers TD; Grey J; Schwarz DA; Heise CE; Haelewyn J; Mistry MS; Goodfellow VS
Bioorg Med Chem Lett; 2007 May; 17(9):2535-9. PubMed ID: 17329101
[TBL] [Abstract][Full Text] [Related]
17. Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design.
Tice CM; Zhao W; Xu Z; Cacatian ST; Simpson RD; Ye YJ; Singh SB; McKeever BM; Lindblom P; Guo J; Krosky PM; Kruk BA; Berbaum J; Harrison RK; Johnson JJ; Bukhtiyarov Y; Panemangalore R; Scott BB; Zhao Y; Bruno JG; Zhuang L; McGeehan GM; He W; Claremon DA
Bioorg Med Chem Lett; 2010 Feb; 20(3):881-6. PubMed ID: 20064717
[TBL] [Abstract][Full Text] [Related]
18. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
Norman MH; Zhu J; Fotsch C; Bo Y; Chen N; Chakrabarti P; Doherty EM; Gavva NR; Nishimura N; Nixey T; Ognyanov VI; Rzasa RM; Stec M; Surapaneni S; Tamir R; Viswanadhan VN; Treanor JJ
J Med Chem; 2007 Jul; 50(15):3497-514. PubMed ID: 17585749
[TBL] [Abstract][Full Text] [Related]
19. Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonists.
Sinz C; Chang J; Lins AR; Brady E; Candelore M; Dallas-Yang Q; Ding V; Jiang G; Lin Z; Mock S; Qureshi S; Salituro G; Saperstein R; Shang J; Szalkowski D; Tota L; Vincent S; Wright M; Xu S; Yang X; Zhang B; Tata J; Kim R; Parmee E
Bioorg Med Chem Lett; 2011 Dec; 21(23):7131-6. PubMed ID: 22001094
[TBL] [Abstract][Full Text] [Related]
20. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
